These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 22169637

  • 1. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas].
    Shen XX, Yu L, Bi R, Yang WT.
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):511-6. PubMed ID: 22169637
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN, Zeng LX, Li YH, Liu YZ, Wu JY, Li L, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct 25; 52(10):687-696. PubMed ID: 29060967
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr 25; 42(4):227-32. PubMed ID: 17631760
    [Abstract] [Full Text] [Related]

  • 6. Grading ovarian serous carcinoma using a two-tier system.
    Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, Silva EG.
    Am J Surg Pathol; 2004 Apr 25; 28(4):496-504. PubMed ID: 15087669
    [Abstract] [Full Text] [Related]

  • 7. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas].
    Wang A, Lu L, Wang Y, Sun Y, Zhang Y, Guo C, Gu Y, Liu A.
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan 25; 43(1):20-4. PubMed ID: 24713244
    [Abstract] [Full Text] [Related]

  • 8. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J, Shi JL, Shen DH, Chen YX, Song QJ.
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul 25; 41(7):433-7. PubMed ID: 22932451
    [Abstract] [Full Text] [Related]

  • 9. [Expressions and clinical significances of paired box gene 2 and cyclin D1 in advanced ovarian serous carcinoma].
    Song Y, Zuo J, Huang X, Shen GH, Liu XY, Zhang X.
    Zhonghua Zhong Liu Za Zhi; 2017 Dec 23; 39(12):891-895. PubMed ID: 29262504
    [Abstract] [Full Text] [Related]

  • 10. Distinct subtypes of serous ovarian carcinoma identified by p53 determination.
    Lassus H, Leminen A, Lundin J, Lehtovirta P, Butzow R.
    Gynecol Oncol; 2003 Dec 23; 91(3):504-12. PubMed ID: 14675668
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems.
    Vang R, Shih IeM, Kurman RJ.
    Adv Anat Pathol; 2009 Sep 23; 16(5):267-82. PubMed ID: 19700937
    [Abstract] [Full Text] [Related]

  • 14. Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma.
    Shin K, Kim KH, Yoon MS, Suh DS, Lee JY, Kim A, Eo W.
    Adv Clin Exp Med; 2016 Sep 23; 25(3):513-21. PubMed ID: 27629740
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.
    Tung CS, Mok SC, Tsang YT, Zu Z, Song H, Liu J, Deavers MT, Malpica A, Wolf JK, Lu KH, Gershenson DM, Wong KK.
    Mod Pathol; 2009 Sep 23; 22(9):1243-50. PubMed ID: 19525924
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.
    Hsu CY, Bristow R, Cha MS, Wang BG, Ho CL, Kurman RJ, Wang TL, Shih IeM.
    Clin Cancer Res; 2004 Oct 01; 10(19):6432-6. PubMed ID: 15475429
    [Abstract] [Full Text] [Related]

  • 20. PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors.
    Lohneis P, Darb-Esfahani S, Dietel M, Braicu I, Sehouli J, Arsenic R.
    Anticancer Res; 2015 Nov 01; 35(11):6329-34. PubMed ID: 26504072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.